Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenichi Koyama
The G2 Checkpoint Inhibitor CBP-93872 Increases the Sensitivity of Colorectal and Pancreatic Cancer Cells to Chemotherapy
PLoS ONE
Multidisciplinary
Related publications
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
PLoS ONE
Multidisciplinary
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells
Asian Pacific Journal of Cancer Prevention
Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Knockdown of MTDH Increases Drug Sensitivity to HDAC Inhibitor and TRAIL Combination Treatment in Endometrial Cancer Cells
Proceedings in Obstetrics and Gynecology
PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
BML-275, an AMPK Inhibitor, Induces DNA Damage, G2/M Arrest and Apoptosis in Human Pancreatic Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
WEE1 Kinase Inhibition Reverses G2/M Cell Cycle Checkpoint Activation to Sensitize Cancer Cells to Immunotherapy
OncoImmunology
Oncology
Allergy
Immunology
Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
Scientific Reports
Multidisciplinary